Back to search
FDAFDA · Food and drugs·Recall number D-0644-2025

chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15

Published September 17, 2025 · Recall initiated: August 25, 2025

Summary

FDA records drug Class II recall D-0644-2025, published September 17, 2025 and initiated August 25, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 2003 cartons; Lot: Lot # 47089, Exp 12/31/25; 47604, Exp 03/31/26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of a foreign substance.

What to do

Voluntary: Firm initiated · E-Mail

Get an email if CHLORPROMAZINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CHLORPROMAZINE HYDROCHLORIDE
Manufacturer
AvKARE
Distributor
USA Nationwide
Lot
Lot # 47089, Exp 12/31/25; 47604, Exp 03/31/26
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15 recalled?

Yes. FDA published recall D-0644-2025 on September 17, 2025. Reported hazard: Presence of a foreign substance.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CHLORPROMAZINE HYDROCHLORIDE.